Holen Sie sich die Stockscreener-App
0.354
2.91%
0.01
Schlusskurs vom Vortag:
$0.344
Offen:
$0.34
24-Stunden-Volumen:
85,765
Relative Volume:
0.17
Marktkapitalisierung:
$7.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.05M
KGV:
-0.1647
EPS:
-2.15
Netto-Cashflow:
$-17.78M
1W Leistung:
+1.14%
1M Leistung:
+5.23%
6M Leistung:
-91.73%
1J Leistung:
-89.46%
1-Tages-Spanne:
$0.3317
$0.358
1-Wochen-Bereich:
$0.3317
$0.394
52-Wochen-Spanne:
$0.3011
$5.62
Envveno Medical Corporation Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corporation
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Vergleichen Sie NVNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.354 | 6.95M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
125.50 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.74 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.18 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.49 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.14 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Envveno Medical Corporation Aktie (NVNO) Neueste Nachrichten
Profit Review: Is enVVeno Medical Corporation (5HJ) stock worth buying before Fed action2025 Top Decliners & High Accuracy Investment Entry Signals - ulpravda.ru
Contrasting Penumbra (NYSE:PEN) & enVVeno Medical (NASDAQ:NVNO) - Defense World
Is enVVeno Medical Corporation (5HJ) stock worth buying before Fed actionWeekly Trade Recap & Accurate Entry and Exit Point Alerts - ulpravda.ru
How enVVeno Medical Corporation stock reacts to job market dataRate Hike & Precise Swing Trade Alerts - ulpravda.ru
Is enVVeno Medical Corporation stock a buy for dividend growth2025 Technical Overview & Community Verified Watchlist Alerts - ulpravda.ru
Is enVVeno Medical Corporation (5HJ) stock positioned for secular growthJuly 2025 Final Week & Short-Term Trading Opportunity Alerts - ulpravda.ru
Will enVVeno Medical Corporation stock benefit from sector rotationEntry Point & Consistent Profit Trading Strategies - ulpravda.ru
Can enVVeno Medical Corporation stock double in next 5 yearsGap Down & Daily Volume Surge Signals - ulpravda.ru
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Cape Cod Times
Published on: 2026-01-08 10:56:34 - ulpravda.ru
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Pocono Record
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - Times Herald-Record
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
NVNBW SEC FilingsEnvveno Med Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Can enVVeno Medical Corporation stock deliver sustainable ROE2025 Market Outlook & Verified High Yield Trade Plans - ulpravda.ru
Will enVVeno Medical Corporation stock pay special dividends2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
How enVVeno Medical Corporation stock reacts to inflationary pressuresWeekly Risk Summary & Advanced Technical Signal Analysis - Улправда
How enVVeno Medical Corporation stock benefits from global expansion2025 Bull vs Bear & Daily Stock Momentum Reports - Улправда
Will enVVeno Medical Corporation stock sustain high P E ratios2025 Trading Volume Trends & Technical Entry and Exit Tips - Улправда
Can enVVeno Medical Corporation stock hit record highs againAnalyst Downgrade & Real-Time Market Trend Scan - Улправда
Why enVVeno Medical Corporation stock is rated strong buyJuly 2025 PostEarnings & Stepwise Trade Signal Guides - Улправда
Will enVVeno Medical Corporation stock outperform Nasdaq index2025 Trading Volume Trends & High Accuracy Investment Entry Signals - Улправда
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
[Form 4] enVVeno Medical Corp Insider Trading Activity - Stock Titan
enVVeno Medical (NVNO) CTO surrenders 50,000 performance RSUs - Stock Titan
Is enVVeno Medical Corporation stock ready for breakoutPortfolio Value Summary & Free Verified High Yield Trade Plans - Улправда
Will enVVeno Medical Corporation stock benefit from infrastructure spending2025 AllTime Highs & Accurate Buy Signal Notifications - Улправда
enVVeno Medical (NVNO) details director stock option award of 135,883 - Stock Titan
enVVeno Medical Corp (NVNO) director receives 135,883 stock options - Stock Titan
enVVeno Medical Corp (NVNO) director awarded 135,883 options on December 11, 2025 - Stock Titan
enVVeno Medical Corp (NVNO) director gets 135,883 stock options vesting in 2026 - Stock Titan
EnVVeno Medical shareholders approve reverse stock split, reject equity plan By Investing.com - Investing.com India
enVVeno Medical (NVNO) director sells 4,900 shares under 10b5-1 plan - Stock Titan
enVVeno Medical Holds Annual Stockholders Meeting - TipRanks
EnVVeno Medical shareholders approve reverse stock split, reject equity plan - Investing.com
[8-K] enVVeno Medical Corp Reports Material Event | NVNO SEC FilingForm 8-K - Stock Titan
What drives enVVeno Medical Corporation stock pricePrice Action Analysis & Low Cost Wealth Plans - earlytimes.in
A History of Outperforming Analyst Forecasts and Beating the Odds: enVVeno Medical Corporation (NVNO) - setenews.com
enVVeno Medical Shares Continue to Face Downward Pressure - AD HOC NEWS
Is enVVeno Medical Corporation (5HJ) stock a good hedge against inflation2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
How enVVeno Medical Corporation (5HJ) stock reacts to stronger dollarJuly 2025 Action & Target Return Focused Picks - Newser
Will enVVeno Medical Corporation (5HJ) stock profit from fiscal stimulus2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Why enVVeno Medical Corporation stock is favored by top institutionsEntry Point & Stock Market Timing Techniques - Newser
Is enVVeno Medical Corporation (5HJ) stock undervalued by metricsMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):